What is an S-1/A filing?

An amended S-1 registration statement, typically submitted after SEC staff comments on the original S-1 prospectus.

Does this mean the Injective ETF is approved?

No. The amendment is a procedural step. Approval also requires the SEC to act on a 19b-4 rule filing from the listing exchange.

Which issuer filed the amendment?

21Shares, the Zurich-based crypto ETP issuer that also runs a U.S. joint venture with ARK Invest.

When could the ETF launch?

No launch date is set. Timing depends on SEC review of both the S-1/A and the exchange's 19b-4 filing.

21Shares Files Amended S-1/A for Spot Injective ETF as Altcoin Race Tightens

21Shares filed an amended S-1/A registration statement with the U.S. Securities and Exchange Commission on Thursday for a spot Injective ETF, according to a filing first reported by CryptoBriefing. The amendment lands as issuers stack altcoin ETF applications in Washington, pushing the review pipeline beyond bitcoin and ether. The proposed product would give U.S. investors direct exposure to INJ, the native token of the Injective Layer-1 network.

By Elena Stojanović· AI-assisted· Regulation correspondent

What happened

21Shares filed an amended S-1/A registration statement with the SEC on Thursday covering a spot Injective ETF, per CryptoBriefing, which reported the amendment. An S-1/A is the amended version of the base S-1 prospectus, typically submitted in response to comments from SEC staff during review. The filing is separate from the 19b-4 rule change that a listing exchange must submit for the product to actually trade.

Both tracks generally run in parallel, and both need to close before shares hit a U. S. tape.

21Shares, the Zurich-based issuer behind a suite of European crypto ETPs and a U. S. joint venture with ARK Invest, has been one of the more aggressive filers in the current altcoin push.

Why it matters

The Injective filing widens a queue that already includes spot ETF applications for Solana, XRP, Litecoin, Dogecoin, and other majors on top of the live bitcoin and ether products. Each amendment is a small tell. Staff comments push issuers to sharpen custody language, redemption mechanics, and index methodology, and the fact that 21Shares is refiling rather than withdrawing suggests the dialogue is live.

For INJ specifically, a U. S. -listed spot wrapper would be the first regulated onshore vehicle for a token that has largely traded on offshore venues and DEXs.

That expands the addressable buyer base to registered investment advisors, wirehouses, and 401(k) platforms that cannot touch spot crypto directly.

Market impact

21Shares Files Amended S-1/A for Spot Injective ETF as Altcoin Race Tightens

What happened

Why it matters

Market impact

What to watch

Disclaimer

Key takeaways

Frequently asked

Sources